How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study-Reference-Cited by-同舟云学术

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study

Published:2014-02-21 Issue:3 Volume:77 Page:498-508
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Isambert Nicolas¹,Delord Jean Pierre²,Tourani Jean Marc³,Fumoleau Pierre¹,Ravaud Alain⁴,Pinel Marie Claire⁵,Petain Aurelie⁵,Nguyen Thierry⁶,Nguyen Laurent⁵

Affiliation:

1. Medical Oncology; Centre G.F. Leclerc; Dijon France

2. Institut Claudius Regaud; Toulouse France

3. Chu de Poitiers; Poitiers France

4. Hopital Saint Andre; Bordeaux France

5. Institut de Recherche Pierre Fabre; Pharmacokinetic Oncology Department; Toulouse France

6. Chu Jean Minjoz; Besançon France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12218/fullpdf

Reference27 articles.

1. Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts;Hill;Eur J Cancer,1999

2. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid;Kruczynski;Cancer Chemother Pharmacol,1998

3. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development;Kruczynski;Eur J Cancer,2006

4. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells;Pourroy;Cancer Res,2006

5. Vinflunine: a new microtubule inhibitor agent;Bennouna;Clin Cancer Res,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials;British Journal of Clinical Pharmacology;2018-02-26

2. Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience;Therapeutic Advances in Urology;2016-11-21

3. Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU);Current Oncology Reports;2016-11-03

4. Vinflunine for the treatment of non-small cell lung cancer;Expert Opinion on Investigational Drugs;2016-11

5. A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function;Cancer Chemotherapy and Pharmacology;2016-10-27